1999/01/01 by Evanthia Diamanti‐Kandarakis · 1 citation
Medicine · #Hair Growth and Disorders #Hormonal and reproductive studies #Acne and Rosacea Treatments and Effects #Antiandrogen #Cyproterone acetate #hirsutism #Flutamide #Medicine #Antiandrogens #Acne #Spironolactone #Finasteride #Cyproterone #Polycystic ovary #Hyperandrogenism #Dermatology #Gynecology #Internal medicine #Endocrinology #Androgen #Prostate cancer #Hormone #Prostate #Diabetes mellitus #Cancer
paper · doi:10.2174/1381612805666230111201150
openalex publication_date 1999/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/05/21
Androgenic manifestations in appearance cause not only social and psychological distress for many women, but serious skin, reproductive and metabolic abnormalities as well. Antiandrogen therapy is one of the most promising therapies to treat androgenic disorders. Clinical studies with a variety of agents, including spironolactone, cyproterone acetate, flutamide and finasteride have now proven their utility in the treatment of hirsutism, acne, androgenic alopecia and ovulatory dysfuntion in hyperandrogenic women. Comparative clinical studies, especially with low-dose regimens, suggest that these agents are well tolerated and have the potential for broader clinical utility.